We love combo deals! Ha!
A vaginal gel created to reduce a woman’s risk of infection with the AIDS virus has actually been proven to be MORE effective against preventing contracting genital herpes!
Researchers from the National Institutes of Health, Gilead Sciences Inc. and universities in Belgium and Italy, are suggesting that the microbicide gel developed to fight AIDS in Africa, could lower the incidence of herpes in many women.
Considering an estimated 20% of all sexually active adults have herpes, experts are excited to hear the news, saiyng:
“This could be incredibly helpful. Protection that a woman can control is the holy grail in this field. It’s hard for me to believe that something that protects against both H.I.V. and herpes wouldn’t be appealing to a lot of young American women.”
There was a 54% protection rate against HIV for women consistently using the gel, while there was a 62% protection rate against herpes!
The company behind the breakthrough defense against both HIV and the herp is still debating spending millions to get the drug approved in the US. Even if they press ahead immediately, a rep from the company notes “it would be three to four years before we were ready to submit data” to the FDA.
It sounds like there is definitely some hope on the horizon for a drug that can significantly decrease viral infections of these two STD's!
Tags: africa, aids, drug, fda, herpes, hiv, infection, researchers, sex, std, women